Analyst Vincent Andrews from Morgan Stanley maintained a Buy rating on Eastman Chemical and keeping the price target at $73.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vincent Andrews has given his Buy rating due to a combination of factors that point to improving fundamentals and earnings visibility at Eastman Chemical. Management reaffirmed its FY26 financial framework, emphasizing multiple identifiable earnings drivers, including meaningful benefits from higher asset utilization, lower planned turnarounds, cost‑reduction initiatives, and favorable foreign‑exchange trends.
In addition, Andrews highlights that destocking pressures in key segments like Fibers are on track to ease in the first half of the year, setting up a more favorable volume and pricing backdrop. The company also expects tangible EBITDA contribution from its circularity and methanolysis initiatives, which, combined with normal seasonality and tighter supply‑demand conditions in certain regions, support a constructive outlook for profit growth and justify a positive stance on the stock.
Andrews covers the Basic Materials sector, focusing on stocks such as Sherwin-Williams Company, Olin, and Dow Inc. According to TipRanks, Andrews has an average return of 2.2% and a 65.07% success rate on recommended stocks.
In another report released on February 3, Citi also maintained a Buy rating on the stock with a $78.00 price target.